BULLFROG AI HOLDINGS, INC. Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount
BULLFROG AI HOLDINGS, INC. (BFRG) reported Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount of $1.83 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-19.
Financial Statements › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Components of Deferred Tax Assets
us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount · last filed 2026-03-19
- BULLFROG AI HOLDINGS, INC. valuation allowance, deferred tax asset, increase (decrease), amount for fiscal 2025 was $1.83M, a 15.40% increase from fiscal 2024.
- BULLFROG AI HOLDINGS, INC. valuation allowance, deferred tax asset, increase (decrease), amount for fiscal 2024 was $1.58M, a 37.45% increase from fiscal 2023.
- BULLFROG AI HOLDINGS, INC. valuation allowance, deferred tax asset, increase (decrease), amount for fiscal 2023 was $1.15M, a 96.89% increase from fiscal 2022.
- BULLFROG AI HOLDINGS, INC. valuation allowance, deferred tax asset, increase (decrease), amount for fiscal 2022 was $585.00K.
| Period end | Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount 12 month |
|---|---|
| 2025-12-31 | $1.83M 10-K · filed 2026-03-19 |
| 2024-12-31 | $1.58M 10-K · filed 2026-03-19 |
| 2023-12-31 | $1.15M 10-K · filed 2025-03-14 |
| 2022-12-31 | $585.00K 10-K · filed 2024-03-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B | |
| LISATA THERAPEUTICS, INC. (LSTA) | United States | $0.014B | -2.13 |
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B | |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B |